This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Dysgeusia is a type of taste disorder that causes a person to experience a distorted sense of taste. It is usually caused by an underlying medical condition or medication side effect. Symptoms can vary but typically include a metallic, bitter, or salty taste in the mouth that does not go away. In some cases, the taste may also be sweet or sour. Dysgeusia can be very distressing and make eating difficult. The exact cause of dysgeusia is often unknown, but it may be due to a change in the sense of smell, damage to the taste receptors in the mouth, or changes in the saliva. It can also be caused by certain medications, such as antibiotics, chemotherapeutic agents, or ACE inhibitors. Other possible causes include diabetes, immune system disorders, nutritional deficiencies, and head trauma. Treatment for dysgeusia depends on the underlying cause. If it is due to a medication side effect, the doctor may recommend switching to a different medication. If it is due to an underlying medical condition, the doctor may suggest a course of medication or lifestyle changes to address the condition. In some cases, nutritional supplements may also be recommended.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States